Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M, Lu X, Fan C, Draikiwicz S, Kamat SA, Khan A, Pirozzi G, Patel N, Graham NMH, Ruddy M, Staudinger H, Weinreich D, Stahl N, Yancopoulos GD, Mannent LP. Bachert C, et al. Lancet. 2019 Nov 2;394(10209):1638-1650. doi: 10.1016/S0140-6736(19)31881-1. Epub 2019 Sep 19. Lancet. 2019. PMID: 31543428 Clinical Trial.
Inhaled and nasal corticosteroids: safety aspects.
Passalacqua G, Albano M, Canonica GW, Bachert C, Van Cauwenberge P, Davies RJ, Durham SR, Kontou-Fili K, Horak F, Malling HJ. Passalacqua G, et al. Among authors: bachert c. Allergy. 2000 Jan;55(1):16-33. doi: 10.1034/j.1398-9995.2000.00370.x. Allergy. 2000. PMID: 10696853 Review. No abstract available.
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.
van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, Fokkens WJ, Howarth PH, Lund V, Malling HJ, Mygind N, Passali D, Scadding GK, Wang DY. van Cauwenberge P, et al. Among authors: bachert c. Allergy. 2000 Feb;55(2):116-34. doi: 10.1034/j.1398-9995.2000.00526.x. Allergy. 2000. PMID: 10726726 No abstract available.
Superantigens and nasal polyps.
Bachert C, van Zele T, Gevaert P, De Schrijver L, Van Cauwenberge P. Bachert C, et al. Curr Allergy Asthma Rep. 2003 Nov;3(6):523-31. doi: 10.1007/s11882-003-0065-y. Curr Allergy Asthma Rep. 2003. PMID: 14531975 Review.
EAACI position paper on rhinosinusitis and nasal polyps executive summary.
Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, Jones N, Kalogjera L, Kennedy D, Kowalski M, Malmberg H, Mullol J, Passali D, Stammberger H, Stierna P; EAACI. Fokkens W, et al. Among authors: bachert c. Allergy. 2005 May;60(5):583-601. doi: 10.1111/j.1398-9995.2005.00830.x. Allergy. 2005. PMID: 15813802 No abstract available.
Pharmacological management of nasal polyposis.
Bachert C, Watelet JB, Gevaert P, Van Cauwenberge P. Bachert C, et al. Drugs. 2005;65(11):1537-52. doi: 10.2165/00003495-200565110-00006. Drugs. 2005. PMID: 16033291 Review.
780 results